Trump refuses to ve-toe the line

Trump refuses to ve-toe the line - MarketPulseMarketPulse


Home/Central banks/COVID-19/Newsfeed

Share 0

Trump threatens veto of stimulus bill

President Trump has been relatively quiet of late by his own lofty standards. But he has thrown markets a curveball this morning by threatening to veto the fiscal stimulus bill that has passed through both houses of Congress. The President has stated that direct payments to families are too low and has suggested to Congress that it tries again. In particular, he appears to be riling against the foreign aid allotments and a number of other pork-barrel giveaways buried in the 5,600-page document. Further complicating the issue is that the USD1.4 trillion government funding bill for 2021 is attached to the legislation. If the President does veto the bill, the government will shut down effectively on the 28th of December.

A two-thirds majority vote in favour of the bill by both the Senate and the House of Representatives can override the Presidential veto, if that is the course of action President Trump chooses. Overriding the veto is a relatively rare event in American politics though, and it threatens to add another layer of ambiguity as traders and investors prepared for the holiday season.

The market reaction in Asia has been surprisingly muted with most of the regions stock markets remaining in the green, even as US index futures sink this morning. Asia’s first reaction appears to be that President Trump is bluffing, or that even if Trump vetoes the fiscal stimulus, Congress will act quickly with the necessary votes. Given that many Congressional representatives have probably already left Washington DC for the holidays, that could be complacent. For now, markets appear to be holding of pressing the sell button until the situation clarifies.

Asia’s calendar is relatively quiet, with just Thailand’s rate decision and Singapore inflation to relieve the monotony. The Bank of Thailand will almost keep rates unchanged at 0.50% but may note its displeasure with the baht’s appreciation. Singapore inflation will remain modestly negative, around 0.20% as consumer demand remains muted, and the rising currency pushes down import prices. That is unlikely to change until the end of Q1 2021.

After disappointing US house price data overnight, the US releases a plethora of important data this evening. Initial Jobless Claims could spike above 900,000 for the week, with Durable Goods expected to retreat to 0.60%. Personal Spending is expected to fall 0.40% for November, slightly better than October. Overall, the picture will be one of Covid-19 impacting domestic demand and jobs, although manufacturing remains robust, much as it has in Europe. The fallout should be modest, but if the President exercises the veto, sentiment on financial markets could turn sharply negative. That is likely to result in falling equities and US dollar strength.

This article is for general information purposes only. It is not investment advice or a solution to buy or sell securities. Opinions are the authors; not necessarily that of OANDA Corporation or any of its affiliates, subsidiaries, officers or directors. Leveraged trading is high risk and not suitable for all. You could lose all of your deposited funds.

Jeffrey Halley

With more than 30 years of FX experience – from spot/margin trading and NDFs through to currency options and futures – Jeffrey Halley is OANDA’s senior market analyst for Asia Pacific, responsible for providing timely and relevant macro analysis covering a wide range of asset classes. He has previously worked with leading institutions such as Saxo Capital Markets, DynexCorp Currency Portfolio Management, IG, IFX, Fimat Internationale Banque, HSBC and Barclays. A highly sought-after analyst, Jeffrey has appeared on a wide range of global news channels including Bloomberg, BBC, Reuters, CNBC, MSN, Sky TV, Channel News Asia and the New York Times. He was born in New Zealand and holds an MBA from the Cass Business School.

Jeffrey Halley

Latest posts by Jeffrey Halley (see all)

Original author: Jeffrey Halley


© MarketPulse

Ex Dividend 24/12/2020
Transcenta Closes $105 Million in Crossover Financ...

By accepting you will be accessing a service provided by a third-party external to https://chatpips.com/


Broker Search

Latest Spot Rate

19 January 2021
Market Insights Podcast (Episode 296) - MarketPulseMarketPulse Home/Podcasts Share 0 Jonny Hart speaks to APAC Senior Market Analyst Jeffrey Halley about the week ahead. In this weeks episode, we cover China GDP and 2021 outlook, the US Huawei restri...
19 January 2021
Key risk events today: Limited. (Previous analysis as well as outside sources – italics). EUR/USD: Holiday-thinned liquidity witnessed narrow trading on Monday, despite shaking hands with H4 demand (green) at 1.2040-1.2064 and connecting 38.2% Fibona...
19 January 2021
SAN FRANCISCO and SUZHOU, China, Jan. 19, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cance...
19 January 2021
Canadian dollar dips on mixed data - MarketPulseMarketPulse Home/FX/Newsfeed Share 0 The Canadian dollar is down slightly in the Monday session. Currently, USD/CAD is trading at 1.2759, up 0.22% on the day. Short squeeze boosts US dollar The week end...
19 January 2021

How It Works | About | Contact | Contributors | Privacy Policy | Advertise
© 2009 - 2021 ChatPips. All Rights Reserved. Terms of Use: The content on this website is solely for educational and informational purposes and is not a substitute for official documentation of the original owners. Daily economic news is provided by third-party website. This site is not operated by, sponsored by, endorsed by, or affiliated with any parties in any way. The website owner, the authors, the publishers, and all affiliates of ChatPips.com assume no responsibility or liability for your trading and investment results. You should always check and confirm with several sources with your licensed financial advisor and tax advisor to determine the suitability of any investment before making your final decision. Your continued usage and browsing of information on this website constitute your agreement to this Terms of Use. If you do not agree, please do not proceed to use this website. Brokers Directory: The companies license information were obtained from respective local jurisdiction. All other company and/or product names are trademarks and/or registered trademarks of their respective owners.